交通障碍和糖尿病结果:一个纵向分析
Seth A Berkowitz1,2, Aileen Ochoa3, Myklynn LaPoint2
1University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
交通障碍对糖尿病管理有负面影响. 消除这些障碍与血红蛋白A1c和血压的微小改善有关,但其他因素也对更好的糖尿病结果至关重要.
科学领域:
- 糖尿病管理 糖尿病管理
- 公共卫生 公共卫生
- 健康差异 在健康上的差异
背景情况:
- 交通障碍对管理2型糖尿病等慢性疾病的个人来说是一个重大挑战.
- 获得医疗保健服务和持续的医疗监测对于有效的糖尿病护理至关重要.
研究的目的:
- 调查经历交通障碍和糖尿病健康关键指标之间的关联.
- 量化运输障碍对血红蛋白A1c (HbA1c),血压 (BP) 和LDL胆固醇水平随时间推移的影响.
主要方法:
- 进行了一项纵向队列研究,涉及86,977名2型糖尿病成年人.
- 评估了参与者的运输障碍,并追踪了包括HbA1c,静脉血压 (SBP),腹压 (DBP) 和LDL胆固醇在内的结果,长达36个月.
- 针对性最小损失估计被用来比较在多个时间点上有和没有交通障碍的个体之间的结果.
主要成果:
- 没有运输障碍与12个月后平均HbA1c的统计学显著降低0.09% (P=.0002) 相关.
- 在12个月后没有运输障碍的个体中,也观察到较低的静缩血压 (-0.6 mm Hg) 和平移血压 (-0.3 mm Hg) (分别P=.004和P=.02).
- 运输障碍与LDL胆固醇水平之间没有发现显著的关联.
结论:
- 虽然移除运输障碍对HbA1c和血压产生了适度的积极影响,但影响相对较小.
- 仅仅解决交通障碍可能不足以大幅改善糖尿病的结果;需要考虑其他促成因素的综合方法.
更多相关视频
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
